30 avril 2020
1 min de lecture
[Alerte actualité] Anticorps XAV19
-
-
AuteurEdouard Hueber
-
Publié5 mai 2020
Articles récents
[Press Release] XENOTHERA recruits the first patient in the clinical trial of XON7, its new anti-cancer treatment
November 27, 2023. # Download our press release (english version) # Télécharger...
More[Press Release] French biotech announces its therapeutic potential for oxygen-free patients
October 25, 2023. # Download our press release (english version) # Télécharger...
More[Press Release] New hope for patients: XENOTHERA granted orphan drug designation (ODD ) from the FDA for LIS1 in the treatment of T-lymphomas.
September 12, 2023. # Download our press release (english version) # Télécharger...
More